Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Special issues
    • Subject collections
    • Cell Scientists to Watch
    • First Person
    • Sign up for alerts
  • About us
    • About JCS
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Fast-track manuscripts
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • JCS Prize
    • Manuscript transfer network
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contacts
    • Contact JCS
    • Subscriptions
    • Advertising
    • Feedback
    • Institutional usage stats (logged-in users only)
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

User menu

  • Log in

Search

  • Advanced search
Journal of Cell Science
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

supporting biologistsinspiring biology

Journal of Cell Science

  • Log in
Advanced search

RSS   Twitter  Facebook   YouTube  

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Special issues
    • Subject collections
    • Cell Scientists to Watch
    • First Person
    • Sign up for alerts
  • About us
    • About JCS
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Fast-track manuscripts
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • JCS Prize
    • Manuscript transfer network
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contacts
    • Contact JCS
    • Subscriptions
    • Advertising
    • Feedback
    • Institutional usage stats (logged-in users only)
Commentary
The Mad1–Mad2 balancing act – a damaged spindle checkpoint in chromosome instability and cancer
Scott C. Schuyler, Yueh-Fu Wu, Vivian Jen-Wei Kuan
Journal of Cell Science 2012 125: 4197-4206; doi: 10.1242/jcs.107037
Scott C. Schuyler
Department of Biomedical Sciences, College of Medicine, Chang Gung University, Kwei-Shan, Tao-Yuan, 333 Taiwan, Republic of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: schuyler@mail.cgu.edu.tw
Yueh-Fu Wu
Department of Biomedical Sciences, College of Medicine, Chang Gung University, Kwei-Shan, Tao-Yuan, 333 Taiwan, Republic of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vivian Jen-Wei Kuan
Department of Biomedical Sciences, College of Medicine, Chang Gung University, Kwei-Shan, Tao-Yuan, 333 Taiwan, Republic of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & tables
  • Info & metrics
  • PDF
Loading

Summary

Cancer cells are commonly aneuploid. The spindle checkpoint ensures accurate chromosome segregation by controlling cell cycle progression in response to aberrant microtubule–kinetochore attachment. Damage to the checkpoint, which is a partial loss or gain of checkpoint function, leads to aneuploidy during tumorigenesis. One form of damage is a change in levels of the checkpoint proteins mitotic arrest deficient 1 and 2 (Mad1 and Mad2), or in the Mad1:Mad2 ratio. Changes in Mad1 and Mad2 levels occur in human cancers, where their expression is regulated by the tumor suppressors p53 and retinoblastoma 1 (RB1). By employing a standard assay, namely the addition of a mitotic poison at mitotic entry, it has been shown that checkpoint function is normal in many cancer cells. However, in several experimental systems, it has been observed that this standard assay does not always reveal checkpoint aberrations induced by changes in Mad1 or Mad2, where excess Mad1 relative to Mad2 can lead to premature anaphase entry, and excess Mad2 can lead to a delay in entering anaphase. This Commentary highlights how changes in the levels of Mad1 and Mad2 result in a damaged spindle checkpoint, and explores how these changes cause chromosome instability that can lead to aneuploidy during tumorigenesis.

Introduction

Eukaryotic cells possess a defined complement of chromosomes. Aneuploidy, which is an abnormal change in chromosome number, results from the loss or gain of chromosomes during cell division. Frequently, solid tumors are aneuploid (for example, see Storchova and Kuffer, 2008). This has led to the hypothesis that the development of aneuploidy is a factor that contributes to tumorigenesis (Ganem et al., 2007; Suijkerbuijk and Kops, 2008; Pavelka et al., 2010; Torres et al., 2010; Tang et al., 2011). Furthermore, aneuploidy, and the mechanisms that generate aneuploidy, such as chromosome instability, could serve as targets for anti-cancer therapies.

One pathway that contributes to preventing chromosome instability is the spindle checkpoint (Yu, 2006; Musacchio and Salmon, 2007; Khodjakov and Rieder, 2009; Murray, 2011). The spindle checkpoint is a surveillance mechanism that monitors chromosomes to ensure that they are attached properly to spindle microtubules. In classic experiments, a delay in cell cycle progression was observed until all chromosomes were attached to the spindle, and release from this delay required the chromosomes to be placed under tension (Nicklas and Koch, 1969; Li and Nicklas, 1995; Nicklas, 1997). The genetic basis of the spindle checkpoint was first discovered in two independent screens in which sets of mutant alleles in spindle checkpoint genes were isolated in the budding yeast Saccharomyces cerevisiae (Hoyt et al., 1991; Li and Murray, 1991). Early hypotheses about the state of the spindle checkpoint in cancer cells were varied and included proposals for a complete loss of checkpoint function (Elledge, 1996) as well as for a ‘damaged’ checkpoint (Murray 1992; Li and Benezra, 1996), where ‘damaged’ refers to a partial loss or gain of checkpoint function. Initial observations favored the idea that spindle checkpoint function is lost in cancer cells (Cahill et al., 1998; Jin et al., 1998; Cahill et al., 1999). However, later work found that the checkpoint is essential, even in cancer cells (Kops et al., 2004; Michel et al., 2004). Current hypotheses, thus, favor the idea that a damaged spindle checkpoint contributes to chromosome instability. However, the extent of the contribution, if any, that a damaged checkpoint makes to cancer formation is still under debate (Dalton and Yang, 2009; Gascoigne and Taylor, 2008; Thompson and Compton, 2008; Bakhoum et al., 2009; Khodjakov and Rieder, 2009; Rossio et al., 2010b; Schvartzman et al., 2010; Murray, 2011).

On the molecular level, an increase or decrease in proteins that have a function in the checkpoint can lead to spindle checkpoint damage. Here, we will focus on two core spindle checkpoint proteins: Mad1 and Mad2 (also known as MAD1L1 and MAD2L1 in humans). First, we introduce the spindle checkpoint and highlight the roles for Mad1 and Mad2. We then review how changes in Mad1 or Mad2 levels, as well as in the Mad1:Mad2 ratio, alter spindle checkpoint functions. Finally, we discuss changes in Mad1 and Mad2 levels in cancer cells, and conclude by proposing models for how aberrant checkpoint function caused by these changes could lead to chromosome instability.

The spindle checkpoint – a mechanism to ensure accurate chromosome segregation

In metaphase, chromosomes that are correctly attached – through their kinetochores – to microtubules that originate from opposite spindle poles are ‘bi-oriented’ and are placed under tension by spindle forces (Fig. 1A) (Nicklas, 1997; Maresca and Salmon, 2010). These metaphase chromosomes undergo repeated cycles of ‘breathing’, which is defined as oscillations in the distance between paired sister kinetochores (Inoué and Salmon, 1995; Wan et al., 2009; Wan et al., 2012). When all chromosomes are bi-oriented and under tension, the cell cycle progresses into anaphase.

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.

The spindle checkpoint responds to chromosome attachment and tension. Potential metaphase states for paired sister kinetochores (yellow ovals) on chromosomes (blue) that are held together by cohesin rings (black rings). (A) An example of a chromosome that is attached to microtubules (green lines), bi-oriented, and under tension (stretched yellow ovals). The bi-oriented paired sister kinetochores undergo rounds of ‘breathing’, oscillating between fully stretched and semi-relaxed states (arrows). (B) Chromosome arrangements that could lead to the spindle checkpoint being ‘unsatisfied’: (1) an unattached chromosome, (2) a chromosome where one kinetochore has achieved attachment to microtubules, but the sister kinetochore remains unattached, and (3 and 4) both kinetochores are attached to microtubules, but the kinetochores are not under tension. During syntelic attachment (4), both kinetochores have attached to microtubules from the same spindle pole. During merotelic attachment (5), at least one kinetochore (distorted yellow oval) displays a mixed orientation of microtubule attachment. Merotelic attachments typically do not lead to an unsatisfied checkpoint. However, kinetochores that display syntelic attachment mixed with a small number of merotelic attachments can lead to an unsatisfied checkpoint during error correction (broken line).

The spindle checkpoint ensures accurate chromosome segregation by executing two functions (Khodjakov and Rieder, 2009). First, the checkpoint ‘monitors’ whether chromosomes are correctly attached to microtubules. ‘Monitoring’ starts at mitotic entry and lasts until entry into anaphase, and has been referred to as a state in which the mitotic checkpoint is active. Experimentally, this function is often observed as seeing that Mad2 has localized to kinetochores. Second, the checkpoint generates a signal from kinetochores that inhibits cell cycle progression. When the signal prevents cell cycle progression, the checkpoint is said to be ‘unsatisfied’, and when the checkpoint signal is too weak to inhibit cell cycle progression, the checkpoint is said to be ‘satisfied’. The checkpoint is ‘unsatisfied’ when cells enter mitosis, and becomes ‘satisfied’ at the transition from prometaphase to metaphase. Notably, Mad2 frequently localizes to metaphase kinetochores, which suggests that spindle checkpoint ‘monitoring’ remains active until the end of metaphase (Waters et al., 1998; Khodjakov and Rieder, 2009). However, this low level of Mad2 localization in metaphase is apparently not sufficient to generate a checkpoint signal that is strong enough to inhibit the initiation of the steps that promote cell cycle progression (Clute and Pines, 1999).

A single unattached kinetochore is sufficient for the spindle checkpoint to be ‘unsatisfied’ and for cell cycle progression to be halted (Fig. 1B) (Rieder et al., 1994; Li and Nicklas, 1995; Rieder et al., 1995; Nicklas, 1997). The presence of kinetochores that are attached to microtubules, but not under tension, also causes the checkpoint to be ‘unsatisfied’. These attachments occur naturally during prometaphase, but they can also be induced by the addition and subsequent removal of microtubule-depolymerizing agents from cells (Janicke and LaFountain, 1984; Salmon et al., 2005). Both amphitelic attachment, whereby the system lacks tension, and syntelic attachment, which refers to sister kinetochores that are mono-oriented, lead to an ‘unsatisfied’ checkpoint (Fig. 1B) (Maresca and Salmon, 2010). In response to a lack of kinetochore tension, an error correction mechanism that depends on the activity of the kinase Aurora B promotes the detachment of microtubules from the kinetochore, and thus gives chromosomes another chance to achieve the correct attachment (Lampson and Cheeseman, 2011).

The error correction mechanism is also activated in response to merotelic attachment, which refers to a state whereby both kinetochores are attached, but at least one kinetochore is attached to microtubules from both spindle poles (Fig. 1B) (Salmon et al., 2005; Cimini et al., 2006). Merotelic attachment leads to one distorted kinetochore that is closer to the spindle equator and not ‘breathing’, while its paired sister-kinetochore oscillates normally (Fig. 1B) (Cimini et al., 2004). The inability of cells to completely prevent the occurrence of lagging chromosomes in anaphase has led to the hypothesis that the spindle checkpoint cannot detect merotelic attachments (Fig. 1B, broken line) (Cimini et al., 2001; Cimini et al., 2002; Salmon et al., 2005). Chromosomes that are mostly syntelic, but display a small amount of merotelism, could lead to the checkpoint becoming ‘unsatisfied’ during error correction. However, these kinds of attachments are rare (Janicke and LaFountain, 1984; Salmon et al., 2005).

Molecular mechanism of the spindle checkpoint – the central role of Mad1 and Mad2

On a molecular level, how does the spindle checkpoint delay cell cycle progression when proper kinetochore attachment is not achieved? A primary cell cycle regulator at the metaphase–anaphase transition is the anaphase-promoting complex or cyclosome (APC/C), which, together with the essential co-activator cell division cycle 20 (Cdc20), promotes ubiquitylation of substrates and thereby marks them for proteolysis by the 26S proteasome (Li et al., 1997; Hwang et al., 1998; Lin et al., 1998; Wassmann and Benezra, 1998; Fang et al., 1998). Current hypotheses propose that the metaphase–anaphase transition is determined by the ‘flow’ of Cdc20, which can be defined as a series of sequential protein–protein interactions, through one of two distinct pathways (Fig. 2) (Varetti et al., 2011). From mitotic entry until anaphase, the pool of Cdc20 is renewed by protein synthesis. By ‘flowing’ through one pathway, Cdc20 can activate the APC/C, which allows the APC/C to bind to its substrates, such as securin and cyclin B, and thereby leads to anaphase. Alternatively, when bound by Mad2, Cdc20 ‘flows’ through the checkpoint that leads to cell cycle arrest by initially inactivating the APC/C and subsequent degradation of Cdc20 by the 26S proteasome. The checkpoint controls the metaphase–anaphase transition by controlling which of these pathways Cdc20 follows. The first step in checkpoint signaling, namely the binding of Cdc20 by Mad2, is controlled by Mad1 and Mad2.

Fig. 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.

Mad1 and Mad2 regulate the metaphase–anaphase transition by controlling the flow of Cdc20 into the checkpoint pathway. Cdc20 (green circle) is synthesized continuously during prometaphase and metaphase. If the spindle checkpoint is ‘satisfied’ (thick green arrow), after binding a substrate (orange rod), Cdc20 can activate the APC/C and promote entry into anaphase. If a kinetochore is not attached properly, the spindle checkpoint is ‘unsatisfied’ (thick red arrow). Under these conditions, first Mad2 (red square) and then the Mad3–Bub3 complex (pink rod and circle) bind to Cdc20 to form the MCC. The MCC binds to the APC/C and inactivates it, thereby causing cell cycle arrest. The APC/C is re-activated by p31comet (yellow star), which promotes the disassembly of the MCC and the ubiquitylation of Cdc20. The flow of Cdc20 through the checkpoint pathway is unidirectional and ultimately results in proteasomal degradation (thick blue arrow).

Mad1 and Mad2 physically interact and function together in a hetero-tetrameric complex to initiate the checkpoint signal (Hardwick and Murray, 1995; Chen et al., 1998; Chen et al., 1999). When a kinetochore is not properly attached, the Mad1–Mad2 complex binds to the kinetochore, where Mad1 becomes hyper-phosphorylated and activated by the kinase monopolar spindle 1 (Mps1) (Winey and Huneycutt, 2002; Hewitt et al., 2010). The Mad1–Mad2 complex at the kinetochore serves as a ‘template’ that catalyzes the formation of the Mad2–Cdc20 complex (Fig. 2) (Sironi et al., 2001; Chung and Chen, 2002; Sironi et al., 2002; De Antoni et al., 2005; Nezi et al., 2006; Mapelli et al., 2007; Yang et al., 2008a; Kulukian et al., 2009; Lad et al., 2009; Fava et al., 2011). Formation of the Mad2–Cdc20 complex involves the conversion of Mad2 from an ‘open’ into a ‘closed’ Cdc20-bound conformation (Fig. 2) (Luo et al., 2000; Luo et al., 2004). Mad2 binding to Mad1 also occurs through the ‘closed’ Mad2 conformation (Luo et al., 2002). The conversion of Mad2 from its ‘open’ into its ‘closed’ form involves an extensive conformational change and has been shown to be the rate-limiting step in spindle checkpoint signaling (De Antoni et al., 2005; Vink et al., 2006; Hewitt et al., 2010; Maldonado and Kapoor, 2011; Lau and Murray, 2012). The structures of the ‘open’ and ‘closed’ states have been solved, but the intermediate transition state(s) remains elusive. The ‘closed’ Mad2 protein forms a loop around Cdc20 that is referred to as a ‘safety-belt’ (Sironi et al., 2002). At the kinetochore, or after being released from the kinetochore, the Mad2–Cdc20 heterodimer binds to a pseudo-substrate that comprises the checkpoint proteins Mad3 and Bub3 (budding uninhibited by benzimidazoles 3) (Fig. 2). This Mad2–Cdc20–Mad3–Bub3 complex is called the mitotic checkpoint complex (MCC). The MCC inhibits the APC/C and thereby leads to cell cycle arrest (Fig. 2) (Yu, 2006; Musacchio and Salmon, 2007; Chao et al., 2012).

Mad2 is recycled to its ‘open’ conformation by p31comet (also known as MAD2L1BP) (Fig. 2), which promotes the disassembly of the MCC, re-activates the APC/C, and might also allow the Mad3–Bub3 complex to be recycled (Habu et al., 2002; Xia et al., 2004; Yang et al., 2007; Miniowitz-Shemtov et al., 2010; Hagan et al., 2011; Jia et al., 2011; Ma and Poon, 2011; Teichner et al., 2011; Varetti et al., 2011; Westhorpe et al., 2011). It has been observed that</emph> Cdc20 is ubiquitylated in a p31comet-dependent manner (Díaz-Martínez and Yu, 2007; Reddy et al., 2007; Stegmeier et al., 2007; Nilsson et al., 2008; Ge et al., 2009; Visconti et al., 2010; Varetti et al., 2011). One hypothesis is that Cdc20 ubiquitylation does not necessarily lead to Cdc20 protein degradation, but rather regulates the disassembly of the MCC in a process that is promoted by ubiquitylation mediated by UBE2C (ubiquitin-conjugating enzyme 2C, also known as UBCH10) and is opposed by de-ubiquitylation mediated by ubiquitin C-terminal hydrolase 44 (USP44) (Reddy et al., 2007; Stegmeier et al., 2007). An alternative hypothesis is that p31comet-dependent dismantling of the MCC, and subsequent removal from the APC/C, is coupled with Cdc20 polyubiquitylation and the direct degradation of Cdc20 by the 26S proteasome (Fig. 2), which also involves CUE domain containing 2 (CUEDC2) (Pan and Chen, 2004; Chen, 2007; Díaz-Martínez and Yu, 2007; King et al., 2007; Zeng et al., 2010; Gao et al., 2011; Ma and Poon, 2011; Varetti et al., 2011). This second hypothesis suggests that continuous Cdc20 protein synthesis is required for checkpoint function during prometaphase and metaphase, and support for this idea has recently been found experimentally (Varetti et al., 2011). When the inactive APC/C is re-activated and released from the MCC by p31comet, if the active APC/C continuously encounters Cdc20 that is bound to a substrate, the checkpoint is said to be ‘satisfied’. This will ultimately promote entry into anaphase (Fig. 2). By contrast, if the active APC/C continuously encounters another MCC complex, the spindle checkpoint is said to be ‘unsatisfied’ and the APC/C will become inactive again, which results in the cell cycle remaining arrested (Fig. 2).

Alterations in the levels of Mad1 or Mad2 cause aberrant spindle checkpoint function

Mad1 or Mad2 levels have been manipulated in several experimental models. In budding yeast, the overexpression of Mad1 or Mad2 leads to an increase in chromosome loss (Warren et al., 2002), and overexpression of Mad2 at levels 20-fold higher than the endogenous levels results in mitotic arrest (Rossio et al., 2010a). Decreasing the level of Mad2 by half also increases the rate of chromosome loss and impairs the response from the spindle checkpoint to the loss of kinetochore tension in metaphase but not the response to the presence of a spindle poison at mitotic entry (Lee and Spencer, 2004; Barnhart et al., 2011). In aneuploid budding yeast, a ratio of 1:2 between chromosome X (which carries the MAD2 gene) and chromosome VII (which carries the MAD1 gene) strongly correlates with genomic instability (Zhu et al., 2012). In the fission yeast Schizosaccharomyces pombe, overexpression of Mad2 causes mitotic arrest (He et al., 1997; Kim et al., 1998), and a decrease in the protein levels of Mad1 or Mad2 has been found to disrupt spindle checkpoint function (S. Heinrich and S. Hauf, personal communication). In Caenorhabditis elegans, an increase in the level of Mad2 increases the length of the mitotic delay that is induced by a lack of tension (Essex et al., 2009). In Xenopus laevis egg extracts, an excess of Mad1 removes checkpoint function (Chung and Chen, 2002), and an increase in Mad2 levels causes mitotic arrest (Chen et al., 1998; Fang et al., 1998; Howell et al., 2000). In pre-implantation mouse embryos, a decrease in the level of Mad2 leads to chromosome instability, and overexpression of Mad2 induces a mitotic delay and chromosome instability (Wei et al., 2011). In adult mice, lowering either Mad1 or Mad2, or overexpressing Mad2, disrupts checkpoint function, and increases aneuploidy and tumorigenesis (Michel et al., 2001; Iwanaga et al., 2007; Sotillo et al., 2007). In tissue culture cells, an excess of a microinjected Mad1 protein fragment containing the Mad2-binding site leads to loss of checkpoint function (Howell et al., 2000; Canman et al., 2002; Cimini et al., 2003), and overexpression of Mad2 causes mitotic delay, chromosome instability and leads to the stabilization of kinetochore–microtubule attachments (Howell et al., 2000; Sironi et al., 2001; De Antoni et al., 2005; Kabeche and Compton, 2012).

Several studies have addressed whether the effects observed as a result of changes in Mad1 depend on the presence of Mad2, or whether the effects that occur as a result of changes in Mad2 depend on the presence of Mad1. A mitotic delay induced by excess Mad2 in Xenopus is independent of Mad1, and the addition of excess Mad1 does not remove the delay (Chen et al., 1998; Fang et al., 1998; Chung and Chen, 2002). In budding yeast, C. elegans and mammalian tissue culture cells, the cell cycle delay that is induced by an excess of Mad2 depends on the presence of Mad1 (Sironi et al., 2001; Essex et al., 2009; Rossio et al., 2010a). However, in budding yeast, the requirement for Mad1 can be bypassed by tethering Mad2 to Cdc20 (Lau and Murray, 2012). In tissue culture cells, the stabilization of kinetochore–microtubule attachments induced by excess Mad2 does not require Mad1, although the effect appears to be reduced when Mad1 is absent (Kabeche and Compton, 2012).

The role of the Mad1:Mad2 ratio in spindle checkpoint function

The ‘wild-type’ Mad1:Mad2 ratio is still unknown in most model systems. From the molecular model of the spindle checkpoint (Fig. 2), it would make most sense if there was an excess of Mad2 relative to Mad1, which is the case in a vertebrate cell line, where Mad2 has been shown to be present in a 10-fold excess relative to Mad1 (Shah et al., 2004). However, dual manipulation of Mad1 and Mad2 has led to surprising observations: Mad1 is both an activator and an inhibitor of checkpoint function, and the checkpoint defect that occurs as a result of low Mad2 levels relative to Mad1 can be corrected by a restoring the normal Mad1:Mad2 ratio. In an in vitro biochemical system, the addition of an excess of a Mad1 fragment containing the Mad2-binding site disrupts the interaction between Mad2 and Cdc20, an effect that can be reversed by adding excess Mad2 (Sironi et al., 2002). In budding yeast, a decrease in Mad2 leads to an increase in chromosome loss and the inability to respond to the loss of chromosome tension. However, both phenotypes can be reversed by a compensatory decrease in Mad1 (Barnhart et al., 2011). In Xenopus extracts, excess Mad1 disrupts checkpoint function, and this disruption can be reversed by the addition of excess Mad2 (Chung and Chen, 2002). Thus, at least for some aspects of checkpoint function, the Mad1:Mad2 ratio is more important than the absolute amounts of the proteins.

By contrast, experiments in mice have shown that a decrease in Mad2 cannot be compensated for by a corresponding decrease in Mad1, and double heterozygous knockout mutants display an increase in aneuploidy (Iwanaga et al., 2007). This observation could be the result of, in part, the specific knockout allele of Mad1 that was employed in these experiments, which results in the removal of exon 10 and leads to a partial decrease in the remaining Mad1 protein that is expressed from the wild-type locus in heterozygous mice (Iwanaga et al., 2007). Alternatively, it is possible that different organisms simply display different sensitivities to partial disruption of checkpoint function. In budding yeast and Drosophila melanogaster, Mad2 is not essential, whereas it is required in mice and mammalian cell lines, which appear to be more sensitive to changes in checkpoint function and are more prone to chromosome loss (Dobles et al., 2000; Salmon et al., 2005; Haller et al., 2006). Chromosome loss rates in homozygous mouse mutants might simply be too high to maintain viability (Michel et al., 2001; Iwanaga et al., 2007); this might reflect differences in the spindle assembly rates between different organisms (Khodjakov and Rieder, 2009; Rieder, 2011). Indeed, the work performed using mice has provided the most compelling evidence demonstrating that damaging the spindle checkpoint, by changing the levels of Mad1 or Mad2, can induce the development of aneuploidy and tumorigenesis.

Changes in Mad1 and Mad2 promote tumorigenesis

Many experiments over the past decade have provided evidence for changes in the levels of spindle checkpoint components in cancer cells, although there can be a lot of variation between cells and/or samples and it can be difficult to establish proper normalization controls. Indeed, it has been suggested that the results that provide evidence for a decrease in checkpoint mRNA transcripts or protein levels leading to a decrease in checkpoint function should be discounted (Schvartzman et al., 2010). Although the results from such studies should be considered with care, the volume of evidence [including eight examples for Mad1 (Han et al., 1999; Coe et al., 2006; Osaki et al., 2007; Wang et al., 2008; Schvartzman et al., 2010), and 27 examples for Mad2 (Suijkerbuijk and Kops, 2008; Wang et al., 2008; Burum-Auensen et al., 2010; Schvartzman et al., 2010; Wang et al., 2010; Díaz-Rodríguez et al., 2011; Furlong et al., 2012; Kato et al., 2011; Wang et al., 2012)] for changes in the levels of Mad1 or Mad2 in cancer cells is intriguing. However, a single question from these observations emerges: do changes in Mad1 or Mad2 promote tumorigenesis, or are such changes simply the result of cancer development?

The most compelling answer to this question comes from work in mice. Decreasing Mad1, or increasing or decreasing Mad2 not only leads to aberrant checkpoint function, but also promotes aneuploidy and induces tumorigenesis (Michel et al., 2001; Sotillo et al., 2007; Sotillo et al., 2010; Schvartzman et al., 2011). Recent work has also placed the aberrant overexpression of Mad2 directly downstream of the loss of function of two tumor suppressor pathways that depend on the tumor suppressor proteins p53 and RB1, and the observed defects in chromosome instability and tumorigenesis could be compensated for by lowering Mad2 expression (Chun and Jin, 2003; Hernando et al., 2004; Chi et al., 2009; Schvartzman et al., 2011). In combination with the earlier work, these observations demonstrate, for example, that an increase in Mad2 is both necessary (Schvartzman et al., 2011) and sufficient (Sotillo et al., 2007) for the development of aneuploidy and tumorigenesis.

Models for how changes in Mad1 and Mad2 levels lead to a damaged checkpoint

Excess Mad1 competes with Cdc20 for binding to Mad2. This competition could have two consequences: the generation of a pool of free Cdc20 that can promote the ubiquitylation of substrates, and a lower level of APC/C inhibition. In combination, these effects cause premature entry into anaphase (Fig. 3A). By contrast, an excess of Mad2 could lead to the continuous inactivation of the APC/C by depleting the amount of Cdc20 that is available to bind substrates, and by increasing the amount of APC/C in the inactive MCC-bound form (Fig. 3B). In most experimental systems, this effect requires Mad1, but this is not the case in Xenopus extracts or when Mad2 is artificially tethered to Cdc20 (Fig. 3B, dashed arrow) (Chen et al., 1998; Fang et al., 1998; Howell et al., 2000; Lau and Murray, 2012). The imbalance in the ‘flow’ of Cdc20 into the checkpoint pathway, which leads to its destruction by the 26S proteasome, can cause an extended mitotic arrest (Fig. 3B).

Fig. 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 3.

Model of how excess Mad1 or excess Mad2 could alter the flow of Cdc20 into the checkpoint pathway. An excess of Mad1 or Mad2 disrupts the normal balance of Mad2 binding to Cdc20, which is the first step in checkpoint signaling. (A) In cells with reduced Mad2 levels or an increase in Mad1 levels (blue rectangles), much of the ‘open’ Mad2 (red hexagon) could be sequestered by the free Mad1 dimers. This could lead to a delay in inactivating the APC/C, and allow free Cdc20 (green circle) to promote a premature entry into anaphase. (B) In cells with increased Mad2 levels (red hexagons), much of the Cdc20 might be sequestered into the checkpoint pathway. This could lead to a decrease in the amount of free Cdc20, and, in combination with the continuous inactivation of the APC/C, lead to an extended mitotic arrest.

How do changes in levels of Mad1 and Mad2 lead to chromosome instability?

Hypotheses for the development of aneuploidy, including the development of tetraploids, invoke an increase in syntelic and/or merotelic chromosomes in metaphase, which leads to non-disjunctions or lagging chromosomes in anaphase (Ganem et al., 2007; Storchova and Kuffer, 2008; Suijkerbuijk and Kops, 2008; Pavelka et al., 2010; Schvartzman et al., 2010; Torres et al., 2010; Tang et al., 2011). Lagging chromosomes occur frequently in tissue culture cells (Cimini et al., 2001; Salmon et al., 2005), and are the most common mitotic defect in human tumor cells, where the kinetochores are often distorted, which suggests merotelic attachments (Thompson and Compton, 2008). Reducing the stability of kinetochore–microtubule attachments in cancer cells also suppresses the incidence of lagging chromosomes, which reduces chromosome mis-segregation rates (Bakhoum et al., 2009).

We propose that these observed increases in chromosome instability result from damage to the spindle checkpoint. It has been argued that checkpoint defects do not contribute to the aneuploidy observed in cancer cells, because cancer cells display a functional checkpoint response when spindle poisons are present at mitotic entry (Khodjakov and Rieder, 2009). However, cells harboring either a defect that disrupts rapid switching from a ‘satisfied’ state back to an ‘unsatisfied’ state in metaphase (i.e. excess Mad1), or a defect that prevents switching in metaphase from an ‘unsatisfied’ to ‘satisfied’ state (i.e. excess Mad2), have both been observed to delay cell cycle progression and prevent chromosome loss when spindle poisons are present at mitotic entry (Chen et al., 1998; De Antoni et al., 2005; Barnhart et al., 2011).

Cells enter mitosis with all chromosomes unattached and with other G2-M checkpoints active (Rieder, 2011). Thus, rapid spindle checkpoint switching from a ‘satisfied’ to an ‘unsatisfied’ state is crucial for cell cycle arrest only in metaphase, after all chromosomes have been bi-oriented and APC/C-dependent destruction of cyclin B has been initiated (Clute and Pines, 1999). If a metaphase kinetochore loses the correct attachment(s), rapid checkpoint switching to the ‘unsatisfied’ state is necessary to prevent premature entry into anaphase. Spindle checkpoint switching in metaphase occurs within a minute of the loss of tension, even while microtubules are mostly still attached to kinetochores (McEwen et al., 1997; Clute and Pines, 1999; Wan et al., 2009). Excess Mad1 can result in cells with a damaged checkpoint; they can arrest the cell cycle if they enter mitosis in the presence of a spindle poison, but they cannot arrest the cell cycle in response to the loss of tension that is induced in metaphase, and display an increase in chromosome loss (Barnhart et al., 2011). These defects can be reversed by a compensatory change that restores the Mad1:Mad2 ratio, even when the total amounts of the Mad1 and Mad2 proteins are only half of the normal levels (Barnhart et al., 2011).

Mitotic delays that are induced by a variety of mechanisms also lead to chromosome mis-segregation (Dalton and Yang, 2009; Rossio et al., 2010b; Schvartzman et al., 2010), and mitotic delays have been observed in cancer cells (Sisken et al., 1982; Sisken et al., 1985; Yang et al., 2008b). We propose that a checkpoint that cannot be ‘satisfied’ because of the presence of excess Mad2, even when chromosomes are correctly bi-oriented, results in merotelic attachments through three routes: (1) as a result of the loss of microtubule attachment during chromosome ‘breathing’, (2) as a result of an expansion in the kinetochore microtubule-binding surface area, and (3) as a result of a disruption in the Aurora B-dependent error correction mechanism (Fig. 4).

Fig. 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 4.

An excess of Mad2 leads to merotelic chromosomes. In the presence of an excess of Mad2, cells remain arrested in metaphase (left) even when bi-orientation and tension have been achieved. This extended arrest could lead to the development of merotelic chromosome attachments through three possible mechanisms: (1) during extended periods of kinetochore ‘breathing’ (left), a kinetochore might relax enough to trigger the loss of tension and microtubule detachment (top), which could lead to merotelic attachment (right), (2) an expansion in the binding surface area between kinetochores and microtubules could allow additional microtubules to bind to the kinetochore (bottom middle) that would lead to merotelic attachment, and/or (3) disruption of the error correction mechanism can promote the accumulation of merotelic attachments (bi-directional arrows). If a single merotelic attachment develops, the paired sister kinetochore is also more likely to develop a merotelic attachment (bottom right).

Once chromosomes are bi-oriented, the paired sister kinetochores ‘breathe’. In PtK1 cells, these oscillations normally last for ∼23 minutes, from the time when the last chromosome is bi-oriented at the end of prometaphase until the initiation of anaphase (Rieder et al., 1994). In metaphase the average individual kinetochore–microtubule attachment half-life is 5–7 minutes (Cassimeris et al., 1990; Shelden and Wadsworth, 1996; Zhai et al., 1995; Bakhoum et al., 2009). Bi-oriented, ‘breathing’ metaphase chromosomes were observed to be less than 1.1 µm apart (i.e. in a state where they lack tension) for only 1% of the time (Wan et al., 2012). Thus, during a normal PtK1 metaphase, bi-oriented sister kinetochores on a single chromosome would, on average, only experience a lack of tension for ∼14 seconds, and each kinetochore–microtubule attachment site would cycle through three or four rounds of detachment and reattachment. In an extended mitotic arrest that lasts, for example, 4 hours, each kinetochore–microtubule attachment site could cycle through 40 rounds of the detachment–reattachment cycle, and each chromosome could experience a lack of tension for several minutes, which might be sufficient to cause activation of the Aurora B error correction mechanism and thereby lead to additional microtubule detachments (Fig. 4). The subsequent attachment state of the chromosome would depend on which spindle pole the next microtubule reattached from, which could lead to a merotelic chromosome (Fig. 4, right).

A second possible route to the development of merotelic chromosomes could result from the structural changes in kinetochores that have been observed during prolonged mitotic arrests. During mitotic arrest in the absence of microtubules, kinetochores appear to expand and curve into a ‘crescent’ shape. In metaphase, anaphase, and in a mitotic arrest where microtubules stay bound to the kinetochores, the microtubule-binding surface area of kinetochores also increases (McEwen et al., 1997; McEwen et al., 1998), but not to the same extent as in the absence of microtubules. This increase in surface area could allow new microtubule attachments to occur, which could lead to merotelic chromosomes (Fig. 4, bottom).

When Mad2 is present at normal levels, a prolonged metaphase arrest, where the Aurora B error correction mechanism is functioning rapidly, does not lead to a substantial change in the number of merotelic kinetochores in metaphase (Cimini et al., 2003; Khodjakov and Rieder, 2009). This suggests that the formation of new merotelic kinetochores and their removal by the error correction mechanism are happening continuously, and the number of merotelic kinetochores remains at a steady-state level. However, once one sister kinetochore becomes merotelic, the probability that its sister kinetochore will also become merotelic increases (Fig. 4, bottom right) (Cimini et al., 2002). Indeed, an extended metaphase arrest leads to an increase in the average number of merotelic kinetochores per cell during metaphase in cells that have at least one merotelic attachment, and a corresponding increase in the average number of anaphase lagging chromosomes per cell in cells that have at least one lagging chromosome (Cimini et al., 2003).

Finally, regardless of the route through which merotelic attachment is brought about, recent observations have revealed that overexpression of Mad2 leads to the stabilization of kinetochore–microtubule attachments by disrupting the Aurora-B-dependent error correction mechanism (Kabeche and Compton, 2012). This disruption exacerbates merotelic attachments by trapping chromosomes in an aberrant merotelic state (Fig. 4). Cells eventually proceed into anaphase with lagging chromosomes because of mitotic ‘slippage’ or ‘adaptation’ (Dalton and Yang, 2009; Rossio et al., 2010b; Schvartzman et al., 2010), and display chromosome instability, which leads to the development of aneuploidy during tumorigenesis.

Conclusions and perspectives

The concept that a damaged mitotic spindle checkpoint contributes directly to the development of aneuploidy and tumorigenesis is likely to be a primary train of thought in the coming decade in cancer cell biology. One mechanism that leads to damage in the pathway is a change in the levels of Mad1 and Mad2, or an imbalance in the Mad1:Mad2 ratio. In vivo evidence for this interpretation has been observed in several model organisms, and has been buttressed by in vitro biochemistry. Changes in the levels of Mad1 and Mad2 have been detected in many cancer cell lines and tumor biopsy samples. Steps are being taken to employ changes in Mad1 and Mad2 as cancer biomarkers and to specifically target this part of the checkpoint pathway as a new strategy in developing potential anti-cancer therapies.

In the future, the consequences of changing the levels of Mad1 and Mad2, and the ratio between them, should be explored. The levels of both Mad1 and Mad2 transcripts and/or proteins should be simultaneously measured, because a single measurement is not sufficient to determine the degree of checkpoint function. These measurements should also be coupled with measurements of other checkpoint pathway regulators, notably p31comet and CUEDC2 (Habu et al., 2002; Gao et al., 2011). The binding between Mad1 and Mad2 is at the heart of the checkpoint mechanism, and the recent discovery of other Mad1- and Mad2-binding partners is noteworthy (Zhang et al., 2009; Lee et al., 2010; Lussi et al., 2010; Orth et al., 2011).

At the cellular level, when investigating spindle checkpoint function in cancer cells, it is important to consider that cells might harbor a damaged spindle checkpoint that remains fully functional in response to the presence of spindle poisons at mitotic entry. It will, therefore, be essential to: (1) measure the wild-type in situ rate of mitotic progression from nuclear envelope breakdown to anaphase in a cell type that matches that of the cancer cells under study in tissue culture; (2) measure the rate at which the checkpoint can switch from the ‘satisfied’ state back to the ‘unsatisfied’ state when a kinetochore–microtubule attachment defect is introduced specifically in metaphase in matched normal and cancer cells; and (3) determine the consequences on chromosome segregation, with special attention paid to non-disjunction events and lagging chromosomes, after the induction of a mitotic delay induced by Mad2 overexpression.

Acknowledgments

We wish to thank Rong Li (Stowers Institute, Kansas City, MO, USA), and Stephanie Heinrich and Silke Hauf (Friedrich Miescher Laboratory of the Max Planck Society, Tuebingen, Germany) for permission to share unpublished observations.

Footnotes

  • Funding

    This work was supported by grants from the Chang Gung Memorial Hospital [grant numbers CMRP-D190212, CMRP-D190213], the Taiwan Ministry of Education [grant numbers EMRP–D1A0711, EMRP–D1B0221]; and the Taiwan National Science Council [grant number NMRP–D1A1201] to S.C.S.

  • © 2012. Published by The Company of Biologists Ltd

References

  1. ↵
    1. Bakhoum, S. F.,
    2. Thompson, S. L.,
    3. Manning, A. L. and
    4. Compton, D. A.
    (2009). Genome stability is ensured by temporal control of kinetochore-microtubule dynamics. Nat. Cell Biol. 11, 27–35. doi:10.1038/ncb1809
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Barnhart, E. L.,
    2. Dorer, R. K.,
    3. Murray, A. W. and
    4. Schuyler, S. C.
    (2011). Reduced Mad2 expression keeps relaxed kinetochores from arresting budding yeast in mitosis. Mol. Biol. Cell 22, 2448–2457. doi:10.1091/mbc.E09-01-0029
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Burum–Auensen, E.,
    2. Skotheim, R. I.,
    3. Schjølberg, A. R.,
    4. Røislien, J.,
    5. Lothe, R. A. and
    6. Clausen, O. P.
    (2010). Spindle proteins are differentially expressed in the various histological subtypes of testicular germ cell tumors. J. Carcinog. 9, 1. doi:10.4103/1477-3163.60358
    OpenUrlCrossRefPubMed
  4. ↵
    1. Cahill, D. P.,
    2. Lengauer, C.,
    3. Yu, J.,
    4. Riggins, G. J.,
    5. Willson, J. K.,
    6. Markowitz, S. D.,
    7. Kinzler, K. W. and
    8. Vogelstein, B.
    (1998). Mutations of mitotic checkpoint genes in human cancers. Nature 392, 300–303. doi:10.1038/32688
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Cahill, D. P.,
    2. da Costa, L. T.,
    3. Carson–Walter, E. B.,
    4. Kinzler, K. W.,
    5. Vogelstein, B. and
    6. Lengauer, C.
    (1999). Characterization of MAD2B and other mitotic spindle checkpoint genes. Genomics 58, 181–187. doi:10.1006/geno.1999.5831
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Canman, J. C.,
    2. Sharma, N.,
    3. Straight, A.,
    4. Shannon, K. B.,
    5. Fang, G. and
    6. Salmon, E. D.
    (2002). Anaphase onset does not require the microtubule-dependent depletion of kinetochore and centromere-binding proteins. J. Cell Sci. 115, 3787–3795. doi:10.1242/jcs.00057
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Cassimeris, L.,
    2. Rieder, C. L.,
    3. Rupp, G. and
    4. Salmon, E. D.
    (1990). Stability of microtubule attachment to metaphase kinetochores in PtK1 cells. J. Cell Sci. 96, 9–15.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Chao, W. C.,
    2. Kulkarni, K.,
    3. Zhang, Z.,
    4. Kong, E. H. and
    5. Barford, D.
    (2012). Structure of the mitotic checkpoint complex. Nature 484, 208–213. doi:10.1038/nature10896
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Chen, R. H.
    (2007). Dual inhibition of Cdc20 by the spindle checkpoint. J. Biomed. Sci. 14, 475–479. doi:10.1007/s11373-007-9157-3
    OpenUrlCrossRefPubMed
  10. ↵
    1. Chen, R. H.,
    2. Shevchenko, A.,
    3. Mann, M. and
    4. Murray, A. W.
    (1998). Spindle checkpoint protein Xmad1 recruits Xmad2 to unattached kinetochores. J. Cell Biol. 143, 283–295. doi:10.1083/jcb.143.2.283
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Chen, R. H.,
    2. Brady, D. M.,
    3. Smith, D.,
    4. Murray, A. W. and
    5. Hardwick, K. G.
    (1999). The spindle checkpoint of budding yeast depends on a tight complex between the Mad1 and Mad2 proteins. Mol. Biol. Cell 10, 2607–2618.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Chi, Y. H.,
    2. Ward, J. M.,
    3. Cheng, L. I.,
    4. Yasunaga, J. and
    5. Jeang, K. T.
    (2009). Spindle assembly checkpoint and p53 deficiencies cooperate for tumorigenesis in mice. Int. J. Cancer 124, 1483–1489. doi:10.1002/ijc.24094
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    1. Chun, A. C. and
    2. Jin, D. Y.
    (2003). Transcriptional regulation of mitotic checkpoint gene MAD1 by p53. J. Biol. Chem. 278, 37439–37450. doi:10.1074/jbc.M307185200
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Chung, E. and
    2. Chen, R. H.
    (2002). Spindle checkpoint requires Mad1-bound and Mad1-free Mad2. Mol. Biol. Cell 13, 1501–1511. doi:10.1083/jcb.153.3.517
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Cimini, D.,
    2. Howell, B.,
    3. Maddox, P.,
    4. Khodjakov, A.,
    5. Degrassi, F. and
    6. Salmon, E. D.
    (2001). Merotelic kinetochore orientation is a major mechanism of aneuploidy in mitotic mammalian tissue cells. J. Cell Biol. 153, 517.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Cimini, D.,
    2. Fioravanti, D.,
    3. Salmon, E. D. and
    4. Degrassi, F.
    (2002). Merotelic kinetochore orientation versus chromosome mono-orientation in the origin of lagging chromosomes in human primary cells. J. Cell Sci. 115, 507–515.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Cimini, D.,
    2. Moree, B.,
    3. Canman, J. C. and
    4. Salmon, E. D.
    (2003). Merotelic kinetochore orientation occurs frequently during early mitosis in mammalian tissue cells and error correction is achieved by two different mechanisms. J. Cell Sci. 116, 4213–4225. doi:10.1242/jcs.00716
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Cimini, D.,
    2. Cameron, L. A. and
    3. Salmon, E. D.
    (2004). Anaphase spindle mechanics prevent mis-segregation of merotelically oriented chromosomes. Curr. Biol. 14, 2149–2155. doi:10.1016/j.cub.2004.11.029
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    1. Cimini, D.,
    2. Wan, X.,
    3. Hirel, C. B. and
    4. Salmon, E. D.
    (2006). Aurora kinase promotes turnover of kinetochore microtubules to reduce chromosome segregation errors. Curr. Biol. 16, 1711–1718. doi:10.1016/j.cub.2006.07.022
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    1. Clute, P. and
    2. Pines, J.
    (1999). Temporal and spatial control of cyclin B1 destruction in metaphase. Nat. Cell Biol. 1, 82–87. doi:10.1038/10049
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    1. Coe, B. P.,
    2. Lee, E. H.,
    3. Chi, B.,
    4. Girard, L.,
    5. Minna, J. D.,
    6. Gazdar, A. F.,
    7. Lam, S.,
    8. MacAulay, C. and
    9. Lam, W. L.
    (2006). Gain of a region on 7p22.3, containing MAD1L1, is the most frequent event in small-cell lung cancer cell lines. Genes Chromosomes Cancer 45, 11–19. doi:10.1002/gcc.20260
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    1. Dalton, W. B. and
    2. Yang, V. W.
    (2009). Role of prolonged mitotic checkpoint activation in the formation and treatment of cancer. Future Oncol. 5, 1363–1370. doi:10.2217/fon.09.118
    OpenUrlCrossRefPubMed
  23. ↵
    1. De Antoni, A.,
    2. Pearson, C. G.,
    3. Cimini, D.,
    4. Canman, J. C.,
    5. Sala, V.,
    6. Nezi, L.,
    7. Mapelli, M.,
    8. Sironi, L.,
    9. Faretta, M.,
    10. Salmon, E. D.,
    11. et al.
    (2005). The Mad1/Mad2 complex as a template for Mad2 activation in the spindle assembly checkpoint. Curr. Biol. 15, 214–225. doi:10.1016/j.cub.2005.01.038
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    1. Díaz–Martínez, L. A. and
    2. Yu, H.
    (2007). Running on a treadmill: dynamic inhibition of APC/C by the spindle checkpoint. Cell Div. 2, 23. doi:10.1186/1747-1028-2-23
    OpenUrlCrossRefPubMed
  25. ↵
    1. Díaz–Rodríguez, E.,
    2. Álvarez–Fernández, S.,
    3. Chen, X.,
    4. Paiva, B.,
    5. López–Pérez, R.,
    6. García–Hernández, J. L.,
    7. San Miguel, J. F. and
    8. Pandiella, A.
    (2011). Deficient spindle assembly checkpoint in multiple myeloma. PLoS ONE 6, e27583. doi:10.1371/journal.pone.0027583
    OpenUrlCrossRefPubMed
  26. ↵
    1. Dobles, M.,
    2. Liberal, V.,
    3. Scott, M. L.,
    4. Benezra, R. and
    5. Sorger, P. K.
    (2000). Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2. Cell 101, 635–645. doi:10.1016/S0092-8674(00)80875-2
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    1. Elledge, S. J.
    (1996). Cell cycle checkpoints: preventing an identity crisis. Science 274, 1664–1672. doi:10.1126/science.274.5293.1664
    OpenUrlAbstract/FREE Full Text
  28. ↵
    1. Essex, A.,
    2. Dammermann, A.,
    3. Lewellyn, L.,
    4. Oegema, K. and
    5. Desai, A.
    (2009). Systematic analysis in Caenorhabditis elegans reveals that the spindle checkpoint is composed of two largely independent branches. Mol. Biol. Cell 20, 1252–1267. doi:10.1091/mbc.E08-10-1047
    OpenUrlAbstract/FREE Full Text
  29. ↵
    1. Fang, G.,
    2. Yu, H. and
    3. Kirschner, M. W.
    (1998). The checkpoint protein MAD2 and the mitotic regulator CDC20 form a ternary complex with the anaphase-promoting complex to control anaphase initiation. Genes Dev. 12, 1871–1883. doi:10.1101/gad.12.12.1871
    OpenUrlAbstract/FREE Full Text
  30. ↵
    1. Fava, L. L.,
    2. Kaulich, M.,
    3. Nigg, E. A. and
    4. Santamaria, A.
    (2011). Probing the in vivo function of Mad1:C-Mad2 in the spindle assembly checkpoint. EMBO J. 30, 3322–3336. doi:10.1038/emboj.2011.239
    OpenUrlCrossRefPubMed
  31. ↵
    1. Furlong, F.,
    2. Fitzpatrick, P.,
    3. O'Toole, S.,
    4. Phelan, S.,
    5. McGrogan, B.,
    6. Maguire, A.,
    7. O'Grady, A.,
    8. Gallagher, M.,
    9. Prencipe, M.,
    10. McGoldrick, A.,
    11. et al.
    2012). Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer. J. Pathol. 226, 746–755. doi:10.1002/path.3035
    OpenUrlCrossRefPubMed
  32. ↵
    1. Ganem, N. J.,
    2. Storchova, Z. and
    3. Pellman, D.
    (2007). Tetraploidy, aneuploidy and cancer. Curr. Opin. Genet. Dev. 17, 157–162. doi:10.1016/j.gde.2007.02.011
    OpenUrlCrossRefPubMedWeb of Science
  33. ↵
    1. Gao, Y. F.,
    2. Li, T.,
    3. Chang, Y.,
    4. Wang, Y. B.,
    5. Zhang, W. N.,
    6. Li, W. H.,
    7. He, K.,
    8. Mu, R.,
    9. Zhen, C.,
    10. Man, J. H.,
    11. et al.
    (2011). Cdk1-phosphorylated CUEDC2 promotes spindle checkpoint inactivation and chromosomal instability. Nat. Cell Biol. 13, 924–933. doi:10.1038/ncb2287
    OpenUrlCrossRefPubMedWeb of Science
  34. ↵
    1. Gascoigne, K. E. and
    2. Taylor, S. S.
    (2008). Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 14, 111–122. doi:10.1016/j.ccr.2008.07.002
    OpenUrlCrossRefPubMedWeb of Science
  35. ↵
    1. Ge, S.,
    2. Skaar, J. R. and
    3. Pagano, M.
    (2009). APC/C- and Mad2-mediated degradation of Cdc20 during spindle checkpoint activation. Cell Cycle 8, 167–171. doi:10.4161/cc.8.1.7606
    OpenUrlCrossRefPubMedWeb of Science
  36. ↵
    1. Habu, T.,
    2. Kim, S. H.,
    3. Weinstein, J. and
    4. Matsumoto, T.
    (2002). Identification of a MAD2-binding protein, CMT2, and its role in mitosis. EMBO J. 21, 6419–6428. doi:10.1093/emboj/cdf659
    OpenUrlCrossRefPubMedWeb of Science
  37. ↵
    1. Hagan, R. S.,
    2. Manak, M. S.,
    3. Buch, H. K.,
    4. Meier, M. G.,
    5. Meraldi, P.,
    6. Shah, J. V. and
    7. Sorger, P. K.
    (2011). p31(comet) acts to ensure timely spindle checkpoint silencing subsequent to kinetochore attachment. Mol. Biol. Cell 22, 4236–4246. doi:10.1091/mbc.E11-03-0216
    OpenUrlAbstract/FREE Full Text
  38. ↵
    1. Haller, K.,
    2. Kibler, K. V.,
    3. Kasai, T.,
    4. Chi, Y. H.,
    5. Peloponese, J. M.,
    6. Yedavalli, V. S. and
    7. Jeang, K. T.
    (2006). The N-terminus of rodent and human MAD1 confers species-specific stringency to spindle assembly checkpoint. Oncogene 25, 2137–2147. doi:10.1038/sj.onc.1209259
    OpenUrlCrossRefPubMedWeb of Science
  39. ↵
    1. Han, S.,
    2. Park, K.,
    3. Kim, H. Y.,
    4. Lee, M. S.,
    5. Kim, H. J. and
    6. Kim, Y. D.
    (1999). Expression of Mad1 protein inhibits proliferation of cancer cells and inversely correlated with Myc protein expression in primary gastric cancer. Oncol. Rep. 6, 569–574.
    OpenUrlPubMed
  40. ↵
    1. Hardwick, K. G. and
    2. Murray, A. W.
    (1995). Mad1p, a phosphoprotein component of the spindle assembly checkpoint in budding yeast. J. Cell Biol. 131, 709–720. doi:10.1083/jcb.131.3.709
    OpenUrlAbstract/FREE Full Text
  41. ↵
    1. He, X.,
    2. Patterson, T. E. and
    3. Sazer, S.
    (1997). The Schizosaccharomyces pombe spindle checkpoint protein mad2p blocks anaphase and genetically interacts with the anaphase-promoting complex. Proc. Natl. Acad. Sci. USA 94, 7965–7970. doi:10.1073/pnas.94.15.7965
    OpenUrlAbstract/FREE Full Text
  42. ↵
    1. Hernando, E.,
    2. Nahlé, Z.,
    3. Juan, G.,
    4. Diaz–Rodriguez, E.,
    5. Alaminos, M.,
    6. Hemann, M.,
    7. Michel, L.,
    8. Mittal, V.,
    9. Gerald, W.,
    10. Benezra, R.,
    11. et al.
    (2004). Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature 430, 797–802. doi:10.1038/nature02820
    OpenUrlCrossRefPubMedWeb of Science
  43. ↵
    1. Hewitt, L.,
    2. Tighe, A.,
    3. Santaguida, S.,
    4. White, A. M.,
    5. Jones, C. D.,
    6. Musacchio, A.,
    7. Green, S. and
    8. Taylor, S. S.
    (2010). Sustained Mps1 activity is required in mitosis to recruit O-Mad2 to the Mad1-C-Mad2 core complex. J. Cell Biol. 190, 25–34. doi:10.1083/jcb.201002133
    OpenUrlAbstract/FREE Full Text
  44. ↵
    1. Howell, B. J.,
    2. Hoffman, D. B.,
    3. Fang, G.,
    4. Murray, A. W. and
    5. Salmon, E. D.
    (2000). Visualization of Mad2 dynamics at kinetochores, along spindle fibers, and at spindle poles in living cells. J. Cell Biol. 150, 1233–1250. doi:10.1083/jcb.150.6.1233
    OpenUrlAbstract/FREE Full Text
  45. ↵
    1. Hoyt, M. A.,
    2. Totis, L. and
    3. Roberts, B. T.
    (1991). S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function. Cell 66, 507–517. doi:10.1016/0092-8674(81)90014-3
    OpenUrlCrossRefPubMedWeb of Science
  46. ↵
    1. Hwang, L. H.,
    2. Lau, L. F.,
    3. Smith, D. L.,
    4. Mistrot, C. A.,
    5. Hardwick, K. G.,
    6. Hwang, E. S.,
    7. Amon, A. and
    8. Murray, A. W.
    (1998). Budding yeast Cdc20: a target of the spindle checkpoint. Science 279, 1041–1044. doi:10.1126/science.279.5353.1041
    OpenUrlAbstract/FREE Full Text
  47. ↵
    1. Inoué, S. and
    2. Salmon, E. D.
    (1995). Force generation by microtubule assembly/disassembly in mitosis and related movements. Mol. Biol. Cell 6, 1619–1640.
    OpenUrlAbstract/FREE Full Text
  48. ↵
    1. Iwanaga, Y.,
    2. Chi, Y. H.,
    3. Miyazato, A.,
    4. Sheleg, S.,
    5. Haller, K.,
    6. Peloponese, J. M. Jr.,
    7. Li, Y.,
    8. Ward, J. M.,
    9. Benezra, R. and
    10. Jeang, K. T.
    (2007). Heterozygous deletion of mitotic arrest-deficient protein 1 (MAD1) increases the incidence of tumors in mice. Cancer Res. 67, 160–166. doi:10.1158/0008-5472.CAN-06-3326
    OpenUrlAbstract/FREE Full Text
  49. ↵
    1. Janicke, M. A. and
    2. LaFountain, J. R. Jr.
    (1984). Malorientation in half-bivalents at anaphase: analysis of autosomal laggards in untreated, cold-treated, and cold-recovering crane fly spermatocytes. J. Cell Biol. 98, 859–869. doi:10.1083/jcb.98.3.859
    OpenUrlAbstract/FREE Full Text
  50. ↵
    1. Jia, L.,
    2. Li, B.,
    3. Warrington, R. T.,
    4. Hao, X.,
    5. Wang, S. and
    6. Yu, H.
    (2011). Defining pathways of spindle checkpoint silencing: functional redundancy between Cdc20 ubiquitination and p31(comet). Mol. Biol. Cell 22, 4227–4235. doi:10.1091/mbc.E11-05-0389
    OpenUrlAbstract/FREE Full Text
  51. ↵
    1. Jin, D. Y.,
    2. Spencer, F. and
    3. Jeang, K. T.
    (1998). Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 93, 81–91. doi:10.1016/S0092-8674(00)81148-4
    OpenUrlCrossRefPubMedWeb of Science
  52. ↵
    1. Kabeche, L. and
    2. Compton, D. A.
    (2012). Checkpoint-independent stabilization of kinetochore-microtubule attachments by Mad2 in human cells. Curr. Biol. 22, 638–644. doi:10.1016/j.cub.2012.02.030
    OpenUrlCrossRefPubMed
  53. ↵
    1. Kato, T.,
    2. Daigo, Y.,
    3. Aragaki, M.,
    4. Ishikawa, K.,
    5. Sato, M.,
    6. Kondo, S. and
    7. Kaji, M.
    (2011). Overexpression of MAD2 predicts clinical outcome in primary lung cancer patients. Lung Cancer 74, 124–131. doi:10.1016/j.lungcan.2011.01.025
    OpenUrlCrossRefPubMed
  54. ↵
    1. Khodjakov, A. and
    2. Rieder, C. L.
    (2009). The nature of cell-cycle checkpoints: facts and fallacies. J. Biol. 8, 88. doi:10.1186/jbiol195
    OpenUrlCrossRefPubMed
  55. ↵
    1. Kim, S. H.,
    2. Lin, D. P.,
    3. Matsumoto, S.,
    4. Kitazono, A. and
    5. Matsumoto, T.
    (1998). Fission yeast Slp1: an effector of the Mad2-dependent spindle checkpoint. Science 279, 1045–1047. doi:10.1126/science.279.5353.1045
    OpenUrlAbstract/FREE Full Text
  56. ↵
    1. King, E. M.,
    2. van der Sar, S. J. and
    3. Hardwick, K. G.
    (2007). Mad3 KEN boxes mediate both Cdc20 and Mad3 turnover, and are critical for the spindle checkpoint. PLoS ONE 2, e342. doi:10.1371/journal.pone.0000342
    OpenUrlCrossRefPubMed
  57. ↵
    1. Kops, G. J.,
    2. Foltz, D. R. and
    3. Cleveland, D. W.
    (2004). Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint. Proc. Natl. Acad. Sci. USA 101, 8699–8704. doi:10.1073/pnas.0401142101
    OpenUrlAbstract/FREE Full Text
  58. ↵
    1. Kulukian, A.,
    2. Han, J. S. and
    3. Cleveland, D. W.
    (2009). Unattached kinetochores catalyze production of an anaphase inhibitor that requires a Mad2 template to prime Cdc20 for BubR1 binding. Dev. Cell 16, 105–117. doi:10.1016/j.devcel.2008.11.005
    OpenUrlCrossRefPubMedWeb of Science
  59. ↵
    1. Lad, L.,
    2. Lichtsteiner, S.,
    3. Hartman, J. J.,
    4. Wood, K. W. and
    5. Sakowicz, R.
    (2009). Kinetic analysis of Mad2-Cdc20 formation: conformational changes in Mad2 are catalyzed by a C-Mad2-ligand complex. Biochemistry 48, 9503–9515. doi:10.1021/bi900718e
    OpenUrlCrossRefPubMedWeb of Science
  60. ↵
    1. Lampson, M. A. and
    2. Cheeseman, I. M.
    (2011). Sensing centromere tension: Aurora B and the regulation of kinetochore function. Trends Cell Biol. 21, 133–140. doi:10.1016/j.tcb.2010.10.007
    OpenUrlCrossRefPubMedWeb of Science
  61. ↵
    1. Lau, D. T. and
    2. Murray, A. W.
    2012). Mad2 and Mad3 cooperate to arrest budding yeast in mitosis. Curr. Biol. 22, 180–190. doi:10.1016/j.cub.2011.12.029
    OpenUrlCrossRefPubMed
  62. ↵
    1. Lee, M. S. and
    2. Spencer, F. A.
    (2004). Bipolar orientation of chromosomes in Saccharomyces cerevisiae is monitored by Mad1 and Mad2, but not by Mad3. Proc. Natl. Acad. Sci. USA 101, 10655–10660. doi:10.1073/pnas.0404102101
    OpenUrlAbstract/FREE Full Text
  63. ↵
    1. Lee, S. H.,
    2. McCormick, F. and
    3. Saya, H.
    (2010). Mad2 inhibits the mitotic kinesin MKlp2. J. Cell Biol. 191, 1069–1077. doi:10.1083/jcb.201003095
    OpenUrlAbstract/FREE Full Text
  64. ↵
    1. Li, R. and
    2. Murray, A. W.
    (1991). Feedback control of mitosis in budding yeast. Cell 66, 519–531. doi:10.1016/0092-8674(81)90015-5
    OpenUrlCrossRefPubMedWeb of Science
  65. ↵
    1. Li, X. and
    2. Nicklas, R. B.
    (1995). Mitotic forces control a cell-cycle checkpoint. Nature 373, 630–632. doi:10.1038/373630a0
    OpenUrlCrossRefPubMed
  66. ↵
    1. Li, Y. and
    2. Benezra, R.
    (1996). Identification of a human mitotic checkpoint gene: hsMAD2. Science 274, 246–248. doi:10.1126/science.274.5285.246
    OpenUrlAbstract/FREE Full Text
  67. ↵
    1. Li, Y.,
    2. Gorbea, C.,
    3. Mahaffey, D.,
    4. Rechsteiner, M. and
    5. Benezra, R.
    (1997). MAD2 associates with the cyclosome/anaphase-promoting complex and inhibits its activity. Proc. Natl. Acad. Sci. USA 94, 12431–12436. doi:10.1073/pnas.94.23.12431
    OpenUrlAbstract/FREE Full Text
  68. ↵
    1. Lin, M.,
    2. Mendoza, M.,
    3. Kane, L.,
    4. Weinstein, J. and
    5. Sakamoto, K. M.
    (1998). Analysis of cell death in myeloid cells inducibly expressing the cell cycle protein p55Cdc. Exp. Hematol. 26, 1000–1006.
    OpenUrlPubMed
  69. ↵
    1. Luo, X.,
    2. Tang, Z.,
    3. Rizo, J. and
    4. Yu, H.
    (2002). The Mad2 spindle checkpoint protein undergoes similar major conformational changes upon binding to either Mad1 or Cdc20. Mol. Cell 9, 59–71. doi:10.1016/S1097-2765(01)00435-X
    OpenUrlCrossRefPubMedWeb of Science
  70. ↵
    1. Luo, X.,
    2. Fang, G.,
    3. Coldiron, M.,
    4. Lin, Y.,
    5. Yu, H.,
    6. Kirschner, M. W. and
    7. Wagner, G.
    (2000). Structure of the Mad2 spindle assembly checkpoint protein and its interaction with Cdc20. Nat. Struct. Biol. 7, 224–229. doi:10.1038/73338
    OpenUrlCrossRefPubMedWeb of Science
  71. ↵
    1. Luo, X.,
    2. Tang, Z.,
    3. Xia, G.,
    4. Wassmann, K.,
    5. Matsumoto, T.,
    6. Rizo, J. and
    7. Yu, H.
    (2004). The Mad2 spindle checkpoint protein has two distinct natively folded states. Nat. Struct. Mol. Biol. 11, 338–345. doi:10.1038/nsmb748
    OpenUrlCrossRefPubMedWeb of Science
  72. ↵
    1. Lussi, Y. C.,
    2. Shumaker, D. K.,
    3. Shimi, T. and
    4. Fahrenkrog, B.
    (2010). The nucleoporin Nup153 affects spindle checkpoint activity due to an association with Mad1. Nucleus 1, 71–84.
    OpenUrlPubMed
  73. ↵
    1. Ma, H. T. and
    2. Poon, R. Y.
    (2011). Orderly inactivation of the key checkpoint protein mitotic arrest deficient 2 (MAD2) during mitotic progression. J. Biol. Chem. 286, 13052–13059. doi:10.1074/jbc.M110.201897
    OpenUrlAbstract/FREE Full Text
  74. ↵
    1. Maldonado, M. and
    2. Kapoor, T. M.
    (2011). Constitutive Mad1 targeting to kinetochores uncouples checkpoint signalling from chromosome biorientation. Nat. Cell Biol. 13, 475–482. doi:10.1038/ncb2223
    OpenUrlCrossRefPubMedWeb of Science
  75. ↵
    1. Mapelli, M.,
    2. Massimiliano, L.,
    3. Santaguida, S. and
    4. Musacchio, A.
    (2007). The Mad2 conformational dimer: structure and implications for the spindle assembly checkpoint. Cell 131, 730–743. doi:10.1016/j.cell.2007.08.049
    OpenUrlCrossRefPubMedWeb of Science
  76. ↵
    1. Maresca, T. J. and
    2. Salmon, E. D.
    (2010). Welcome to a new kind of tension: translating kinetochore mechanics into a wait-anaphase signal. J. Cell Sci. 123, 825–835. doi:10.1242/jcs.064790
    OpenUrlAbstract/FREE Full Text
  77. ↵
    1. McEwen, B. F.,
    2. Ding, Y. and
    3. Heagle, A. B.
    (1998). Relevance of kinetochore size and microtubule-binding capacity for stable chromosome attachment during mitosis in PtK1 cells. Chromosome Res. 6, 123–132. doi:10.1023/A:1009239013215
    OpenUrlCrossRefPubMedWeb of Science
  78. ↵
    1. McEwen, B. F.,
    2. Heagle, A. B.,
    3. Cassels, G. O.,
    4. Buttle, K. F. and
    5. Rieder, C. L.
    (1997). Kinetochore fiber maturation in PtK1 cells and its implications for the mechanisms of chromosome congression and anaphase onset. J. Cell Biol. 137, 1567–1580. doi:10.1083/jcb.137.7.1567
    OpenUrlAbstract/FREE Full Text
  79. ↵
    1. Michel, L. S.,
    2. Liberal, V.,
    3. Chatterjee, A.,
    4. Kirchwegger, R.,
    5. Pasche, B.,
    6. Gerald, W.,
    7. Dobles, M.,
    8. Sorger, P. K.,
    9. Murty, V. V. and
    10. Benezra, R.
    (2001). MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 409, 355–359. doi:10.1038/35053094
    OpenUrlCrossRefPubMedWeb of Science
  80. ↵
    1. Michel, L.,
    2. Diaz–Rodriguez, E.,
    3. Narayan, G.,
    4. Hernando, E.,
    5. Murty, V. V. and
    6. Benezra, R.
    (2004). Complete loss of the tumor suppressor MAD2 causes premature cyclin B degradation and mitotic failure in human somatic cells. Proc. Natl. Acad. Sci. USA 101, 4459–4464. doi:10.1073/pnas.0306069101
    OpenUrlAbstract/FREE Full Text
  81. ↵
    1. Miniowitz–Shemtov, S.,
    2. Teichner, A.,
    3. Sitry–Shevah, D. and
    4. Hershko, A.
    (2010). ATP is required for the release of the anaphase-promoting complex/cyclosome from inhibition by the mitotic checkpoint. Proc. Natl. Acad. Sci. USA 107, 5351–5356. doi:10.1073/pnas.1001875107
    OpenUrlAbstract/FREE Full Text
  82. ↵
    1. Murray, A. W.
    (1992). Creative blocks: cell-cycle checkpoints and feedback controls. Nature 359, 599–604. doi:10.1038/359599a0
    OpenUrlCrossRefPubMedWeb of Science
  83. ↵
    1. Murray, A. W.
    (2011). A brief history of error. Nat. Cell Biol. 13, 1178–1182. doi:10.1038/ncb2348
    OpenUrlCrossRefPubMedWeb of Science
  84. ↵
    1. Musacchio, A. and
    2. Salmon, E. D.
    (2007). The spindle-assembly checkpoint in space and time. Nat. Rev. Mol. Cell Biol. 8, 379–393. doi:10.1038/nrm2163
    OpenUrlCrossRefPubMedWeb of Science
  85. ↵
    1. Nezi, L.,
    2. Rancati, G.,
    3. De Antoni, A.,
    4. Pasqualato, S.,
    5. Piatti, S. and
    6. Musacchio, A.
    (2006). Accumulation of Mad2-Cdc20 complex during spindle checkpoint activation requires binding of open and closed conformers of Mad2 in Saccharomyces cerevisiae. J. Cell Biol. 174, 39–51. doi:10.1083/jcb.200602109
    OpenUrlAbstract/FREE Full Text
  86. ↵
    1. Nicklas, R. B.
    (1997). How cells get the right chromosomes. Science 275, 632–637. doi:10.1126/science.275.5300.632
    OpenUrlAbstract/FREE Full Text
  87. ↵
    1. Nicklas, R. B. and
    2. Koch, C. A.
    (1969). Chromosome micromanipulation. 3. Spindle fiber tension and the reorientation of mal-oriented chromosomes. J. Cell Biol. 43, 40–50. doi:10.1083/jcb.43.1.40
    OpenUrlAbstract/FREE Full Text
  88. ↵
    1. Nilsson, J.,
    2. Yekezare, M.,
    3. Minshull, J. and
    4. Pines, J.
    (2008). The APC/C maintains the spindle assembly checkpoint by targeting Cdc20 for destruction. Nat. Cell Biol. 10, 1411–1420. doi:10.1038/ncb1799
    OpenUrlCrossRefPubMedWeb of Science
  89. ↵
    1. Orth, M.,
    2. Mayer, B.,
    3. Rehm, K.,
    4. Rothweiler, U.,
    5. Heidmann, D.,
    6. Holak, T. A. and
    7. Stemmann, O.
    (2011). Shugoshin is a Mad1/Cdc20-like interactor of Mad2. EMBO J. 30, 2868–2880. doi:10.1038/emboj.2011.187
    OpenUrlCrossRefPubMed
  90. ↵
    1. Osaki, M.,
    2. Inoue, T.,
    3. Yamaguchi, S.,
    4. Inaba, A.,
    5. Tokuyasu, N.,
    6. Jeang, K. T.,
    7. Oshimura, M. and
    8. Ito, H.
    (2007). MAD1 (mitotic arrest deficiency 1) is a candidate for a tumor suppressor gene in human stomach. Virchows Arch. 451, 771–779. doi:10.1007/s00428-007-0470-z
    OpenUrlCrossRefPubMed
  91. ↵
    1. Pan, J. and
    2. Chen, R. H.
    (2004). Spindle checkpoint regulates Cdc20p stability in Saccharomyces cerevisiae. Genes Dev. 18, 1439–1451. doi:10.1101/gad.1184204
    OpenUrlAbstract/FREE Full Text
  92. ↵
    1. Pavelka, N.,
    2. Rancati, G. and
    3. Li, R.
    (2010). Dr Jekyll and Mr Hyde: role of aneuploidy in cellular adaptation and cancer. Curr. Opin. Cell Biol. 22, 809–815. doi:10.1016/j.ceb.2010.06.003
    OpenUrlCrossRefPubMed
  93. ↵
    1. Reddy, S. K.,
    2. Rape, M.,
    3. Margansky, W. A. and
    4. Kirschner, M. W.
    (2007). Ubiquitination by the anaphase-promoting complex drives spindle checkpoint inactivation. Nature 446, 921–925. doi:10.1038/nature05734
    OpenUrlCrossRefPubMed
  94. ↵
    1. Rieder, C. L.
    (2011). Mitosis in vertebrates: the G2/M and M/A transitions and their associated checkpoints. Chromosome Res. 19, 291–306. doi:10.1007/s10577-010-9178-z
    OpenUrlCrossRefPubMedWeb of Science
  95. ↵
    1. Rieder, C. L.,
    2. Schultz, A.,
    3. Cole, R. and
    4. Sluder, G.
    (1994). Anaphase onset in vertebrate somatic cells is controlled by a checkpoint that monitors sister kinetochore attachment to the spindle. J. Cell Biol. 127, 1301–1310. doi:10.1083/jcb.127.5.1301
    OpenUrlAbstract/FREE Full Text
  96. ↵
    1. Rieder, C. L.,
    2. Cole, R. W.,
    3. Khodjakov, A. and
    4. Sluder, G.
    (1995). The checkpoint delaying anaphase in response to chromosome monoorientation is mediated by an inhibitory signal produced by unattached kinetochores. J. Cell Biol. 130, 941–948. doi:10.1083/jcb.130.4.941
    OpenUrlAbstract/FREE Full Text
  97. ↵
    1. Rossio, V.,
    2. Galati, E. and
    3. Piatti, S.
    (2010b). Adapt or die: how eukaryotic cells respond to prolonged activation of the spindle assembly checkpoint. Biochem. Soc. Trans. 38, 1645–1649. doi:10.1042/BST0381645
    OpenUrlCrossRefPubMedWeb of Science
  98. ↵
    1. Rossio, V.,
    2. Galati, E.,
    3. Ferrari, M.,
    4. Pellicioli, A.,
    5. Sutani, T.,
    6. Shirahige, K.,
    7. Lucchini, G. and
    8. Piatti, S.
    (2010a). The RCS chromatin–remodeling complex influences mitotic exit and adaptation to the spindle assembly checkpoint by controlling the Cdc14 phosphatase. J. Cell Biol. 191, 981–997. doi:10.1083/jcb.201007025
    OpenUrlAbstract/FREE Full Text
  99. ↵
    1. Salmon, E. D.,
    2. Cimini, D.,
    3. Cameron, L. A. and
    4. DeLuca, J. G.
    (2005). Merotelic kinetochores in mammalian tissue cells. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 360, 553–568. doi:10.1098/rstb.2004.1610
    OpenUrlAbstract/FREE Full Text
  100. ↵
    1. Schvartzman, J. M.,
    2. Sotillo, R. and
    3. Benezra, R.
    (2010). Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat. Rev. Cancer 10, 102–115. doi:10.1038/nrc2781
    OpenUrlCrossRefPubMedWeb of Science
  101. ↵
    1. Schvartzman, J. M.,
    2. Duijf, P. H.,
    3. Sotillo, R.,
    4. Coker, C. and
    5. Benezra, R.
    (2011). Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition. Cancer Cell 19, 701–714. doi:10.1016/j.ccr.2011.04.017
    OpenUrlCrossRefPubMedWeb of Science
  102. ↵
    1. Shah, J. V.,
    2. Botvinick, E.,
    3. Bonday, Z.,
    4. Furnari, F.,
    5. Berns, M. and
    6. Cleveland, D. W.
    (2004). Dynamics of centromere and kinetochore proteins; implications for checkpoint signaling and silencing. Curr. Biol. 14, 942–952. doi:10.1016/S0960-9822(04)00381-1
    OpenUrlCrossRefPubMedWeb of Science
  103. ↵
    1. Shelden, E. and
    2. Wadsworth, P.
    1996). Stimulation of microtubule dynamic turnover in living cells treated with okadaic acid. Cell Motil. Cytoskeleton 35, 24–34. doi:10.1093/emboj/20.22.6371
    OpenUrlCrossRefPubMed
  104. ↵
    1. Sironi, L.,
    2. Melixetian, M.,
    3. Faretta, M.,
    4. Prosperini, E.,
    5. Helin, K. and
    6. Musacchio, A.
    (2001). Mad2 binding to Mad1 and Cdc20, rather than oligomerization, is required for the spindle checkpoint. EMBO J. 20, 6371–6382. doi:10.1093/emboj/20.22.6371
    OpenUrlCrossRefPubMedWeb of Science
  105. ↵
    1. Sironi, L.,
    2. Mapelli, M.,
    3. Knapp, S.,
    4. De Antoni, A.,
    5. Jeang, K. T. and
    6. Musacchio, A.
    (2002). Crystal structure of the tetrameric Mad1-Mad2 core complex: implications of a ‘safety belt’ binding mechanism for the spindle checkpoint. EMBO J. 21, 2496–2506. doi:10.1093/emboj/21.10.2496
    OpenUrlAbstract
  106. ↵
    1. Sisken, J. E.,
    2. Bonner, S. V. and
    3. Grasch, S. D.
    (1982). The prolongation of mitotic stages in SV40-transformed vs nontransformed human fibroblast cells. J. Cell. Physiol. 113, 219–223. doi:10.1002/jcp.1041130206
    OpenUrlCrossRefPubMed
  107. ↵
    1. Sisken, J. E.,
    2. Bonner, S. V.,
    3. Grasch, S. D.,
    4. Powell, D. E. and
    5. Donaldson, E. S.
    (1985). Alterations in metaphase durations in cells derived from human tumours. Cell Tissue Kinet. 18, 137–146.
    OpenUrlPubMed
  108. ↵
    1. Sotillo, R.,
    2. Schvartzman, J. M.,
    3. Socci, N. D. and
    4. Benezra, R.
    (2010). Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal. Nature 464, 436–440. doi:10.1038/nature08803
    OpenUrlCrossRefPubMedWeb of Science
  109. ↵
    1. Sotillo, R.,
    2. Hernando, E.,
    3. Díaz–Rodríguez, E.,
    4. Teruya–Feldstein, J.,
    5. Cordón–Cardo, C.,
    6. Lowe, S. W. and
    7. Benezra, R.
    (2007). Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 11, 9–23. doi:10.1016/j.ccr.2006.10.019
    OpenUrlCrossRefPubMedWeb of Science
  110. ↵
    1. Stegmeier, F.,
    2. Rape, M.,
    3. Draviam, V. M.,
    4. Nalepa, G.,
    5. Sowa, M. E.,
    6. Ang, X. L.,
    7. McDonald, E. R. 3rd.,
    8. Li, M. Z.,
    9. Hannon, G. J.,
    10. Sorger, P. K.,
    11. et al.
    (2007). Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities. Nature 446, 876–881. doi:10.1038/nature05694
    OpenUrlCrossRefPubMed
  111. ↵
    1. Storchova, Z. and
    2. Kuffer, C.
    (2008). The consequences of tetraploidy and aneuploidy. J. Cell Sci. 121, 3859–3866. doi:10.1242/jcs.039537
    OpenUrlAbstract/FREE Full Text
  112. ↵
    1. Suijkerbuijk, S. J. and
    2. Kops, G. J.
    (2008). Preventing aneuploidy: the contribution of mitotic checkpoint proteins. Biochim. Biophys. Acta 1786, 24–31.
    OpenUrlPubMed
  113. ↵
    1. Tang, Y. C.,
    2. Williams, B. R.,
    3. Siegel, J. J. and
    4. Amon, A.
    (2011). Identification of aneuploidy-selective antiproliferation compounds. Cell 144, 499–512. doi:10.1016/j.cell.2011.01.017
    OpenUrlCrossRefPubMedWeb of Science
  114. ↵
    1. Teichner, A.,
    2. Eytan, E.,
    3. Sitry–Shevah, D.,
    4. Miniowitz–Shemtov, S.,
    5. Dumin, E.,
    6. Gromis, J. and
    7. Hershko, A.
    (2011). p31comet Promotes disassembly of the mitotic checkpoint complex in an ATP-dependent process. Proc. Natl. Acad. Sci. USA 108, 3187–3192. doi:10.1073/pnas.1100023108
    OpenUrlAbstract/FREE Full Text
  115. ↵
    1. Thompson, S. L. and
    2. Compton, D. A.
    (2008). Examining the link between chromosomal instability and aneuploidy in human cells. J. Cell Biol. 180, 665–672. doi:10.1083/jcb.200712029
    OpenUrlAbstract/FREE Full Text
  116. ↵
    1. Torres, E. M.,
    2. Williams, B. R.,
    3. Tang, Y. C. and
    4. Amon, A.
    (2010). Thoughts on aneuploidy. Cold Spring Harb. Symp. Quant. Biol. 75, 445–451. doi:10.1101/sqb.2010.75.025
    OpenUrlAbstract/FREE Full Text
  117. ↵
    1. Varetti, G.,
    2. Guida, C.,
    3. Santaguida, S.,
    4. Chiroli, E. and
    5. Musacchio, A.
    (2011). Homeostatic control of mitotic arrest. Mol. Cell 44, 710–720. doi:10.1016/j.molcel.2011.11.014
    OpenUrlCrossRefPubMedWeb of Science
  118. ↵
    1. Vink, M.,
    2. Simonetta, M.,
    3. Transidico, P.,
    4. Ferrari, K.,
    5. Mapelli, M.,
    6. De Antoni, A.,
    7. Massimiliano, L.,
    8. Ciliberto, A.,
    9. Faretta, M.,
    10. Salmon, E. D.,
    11. et al.
    (2006). In vitro FRAP identifies the minimal requirements for Mad2 kinetochore dynamics. Curr. Biol. 16, 755–766. doi:10.1016/j.cub.2006.03.057
    OpenUrlCrossRefPubMedWeb of Science
  119. ↵
    1. Visconti, R.,
    2. Palazzo, L. and
    3. Grieco, D.
    (2010). Requirement for proteolysis in spindle assembly checkpoint silencing. Cell Cycle 9, 564–569. doi:10.4161/cc.9.3.10581
    OpenUrlCrossRefPubMedWeb of Science
  120. ↵
    1. Wan, X.,
    2. Cimini, D.,
    3. Cameron, L. A. and
    4. Salmon, E. D.
    (2012). The coupling between sister kinetochore directional instability and oscillations in centromere stretch in metaphase PtK1 cells. Mol. Biol. Cell 23, 1035–1046. doi:10.1091/mbc.E11-09-0767
    OpenUrlAbstract/FREE Full Text
  121. ↵
    1. Wan, X.,
    2. O'Quinn, R. P.,
    3. Pierce, H. L.,
    4. Joglekar, A. P.,
    5. Gall, W. E.,
    6. DeLuca, J. G.,
    7. Carroll, C. W.,
    8. Liu, S. T.,
    9. Yen, T. J.,
    10. McEwen, B. F.,
    11. et al.
    (2009). Protein architecture of the human kinetochore microtubule attachment site. Cell 137, 672–684. doi:10.1016/j.cell.2009.03.035
    OpenUrlCrossRefPubMedWeb of Science
  122. ↵
    1. Wang, L.,
    2. Yin, F.,
    3. Du, Y.,
    4. Chen, B.,
    5. Liang, S.,
    6. Zhang, Y.,
    7. Du, W.,
    8. Wu, K.,
    9. Ding, J. and
    10. Fan, D.
    (2010). Depression of MAD2 inhibits apoptosis and increases proliferation and multidrug resistance in gastric cancer cells by regulating the activation of phosphorylated survivin. Tumour Biol. 31, 225–232. doi:10.1007/s13277-010-0036-6
    OpenUrlCrossRefPubMed
  123. ↵
    1. Wang, L.,
    2. Guo, B.,
    3. Wang, R.,
    4. Jiang, Y.,
    5. Qin, S.,
    6. Liang, S.,
    7. Zhao, Y.,
    8. Guo, W.,
    9. Li, K. and
    10. Fan, X.
    (2012). Inhibition of cell growth and up-regulation of MAD2 in human oesophageal squamous cell carcinoma after treatment with the Src/Abl inhibitor dasatinib. Clin. Sci. (Lond.) 122, 13–24. doi:10.1042/CS20110230
    OpenUrlCrossRefPubMed
  124. ↵
    1. Wang, X.,
    2. Cheung, H. W.,
    3. Chun, A. C.,
    4. Jin, D. Y. and
    5. Wong, Y. C.
    (2008). Mitotic checkpoint defects in human cancers and their implications to chemotherapy. Front. Biosci. 13, 2103–2114. doi:10.2741/2827
    OpenUrlCrossRefPubMed
  125. ↵
    1. Warren, C. D.,
    2. Brady, D. M.,
    3. Johnston, R. C.,
    4. Hanna, J. S.,
    5. Hardwick, K. G. and
    6. Spencer, F. A.
    (2002). Distinct chromosome segregation roles for spindle checkpoint proteins. Mol. Biol. Cell 13, 3029–3041. doi:10.1091/mbc.E02-04-0203
    OpenUrlAbstract/FREE Full Text
  126. ↵
    1. Wassmann, K. and
    2. Benezra, R.
    (1998). Mad2 transiently associates with an APC/p55Cdc complex during mitosis. Proc. Natl. Acad. Sci. USA 95, 11193–11198. doi:10.1073/pnas.95.19.11193
    OpenUrlAbstract/FREE Full Text
  127. ↵
    1. Waters, J. C.,
    2. Chen, R. H.,
    3. Murray, A. W. and
    4. Salmon, E. D.
    (1998). Localization of Mad2 to kinetochores depends on microtubule attachment, not tension. J. Cell Biol. 141, 1181–1191. doi:10.1083/jcb.141.5.1181
    OpenUrlAbstract/FREE Full Text
  128. ↵
    1. Wei, Y.,
    2. Multi, S.,
    3. Yang, C. R.,
    4. Ma, J.,
    5. Zhang, Q. H.,
    6. Wang, Z. B.,
    7. Li, M.,
    8. Wei, L.,
    9. Ge, Z. J.,
    10. Zhang, C. H.,
    11. et al.
    (2011). Spindle assembly checkpoint regulates mitotic cell cycle progression during preimplantation embryo development. PLoS ONE 6, e21557. doi:10.1371/journal.pone.0021557
    OpenUrlCrossRefPubMed
  129. ↵
    1. Westhorpe, F. G.,
    2. Tighe, A.,
    3. Lara–Gonzalez, P. and
    4. Taylor, S. S.
    (2011). p31comet-mediated extraction of Mad2 from the MCC promotes efficient mitotic exit. J. Cell Sci. 124, 3905–3916. doi:10.1242/jcs.093286
    OpenUrlAbstract/FREE Full Text
  130. ↵
    1. Winey, M. and
    2. Huneycutt, B. J.
    (2002). Centrosomes and checkpoints: the MPS1 family of kinases. Oncogene 21, 6161–6169. doi:10.1038/sj.onc.1205712
    OpenUrlCrossRefPubMedWeb of Science
  131. ↵
    1. Xia, G.,
    2. Luo, X.,
    3. Habu, T.,
    4. Rizo, J.,
    5. Matsumoto, T. and
    6. Yu, H.
    (2004). Conformation-specific binding of p31(comet) antagonizes the function of Mad2 in the spindle checkpoint. EMBO J. 23, 3133–3143. doi:10.1038/sj.emboj.7600322
    OpenUrlCrossRefPubMedWeb of Science
  132. ↵
    1. Yang, M.,
    2. Li, B.,
    3. Tomchick, D. R.,
    4. Machius, M.,
    5. Rizo, J.,
    6. Yu, H. and
    7. Luo, X.
    (2007). p31comet blocks Mad2 activation through structural mimicry. Cell 131, 744–755. doi:10.1016/j.cell.2007.08.048
    OpenUrlCrossRefPubMedWeb of Science
  133. ↵
    1. Yang, M.,
    2. Li, B.,
    3. Liu, C. J.,
    4. Tomchick, D. R.,
    5. Machius, M.,
    6. Rizo, J.,
    7. Yu, H. and
    8. Luo, X.
    2008a). Insights into mad2 regulation in the spindle checkpoint revealed by the crystal structure of the symmetric mad2 dimer. PLoS Biol. 6e50. doi:10.1371/journal.pbio.0060050
    OpenUrlCrossRefPubMed
  134. ↵
    1. Yang, Z.,
    2. Loncarek, J.,
    3. Khodjakov, A. and
    4. Rieder, C. L.
    2008b). Extra centrosomes and/or chromosomes prolong mitosis in human cells. Nat. Cell Biol. 10748–751. doi:10.1038/ncb1738
    OpenUrlCrossRefPubMedWeb of Science
  135. ↵
    1. Yu, H.
    (2006). Structural activation of Mad2 in the mitotic spindle checkpoint: the two-state Mad2 model versus the Mad2 template model. J. Cell Biol. 173, 153–157. doi:10.1083/jcb.200601172
    OpenUrlAbstract/FREE Full Text
  136. ↵
    1. Zeng, X.,
    2. Sigoillot, F.,
    3. Gaur, S.,
    4. Choi, S.,
    5. Pfaff, K. L.,
    6. Oh, D. C.,
    7. Hathaway, N.,
    8. Dimova, N.,
    9. Cuny, G. D. and
    10. King, R. W.
    (2010). Pharmacologic inhibition of the anaphase-promoting complex induces a spindle checkpoint-dependent mitotic arrest in the absence of spindle damage. Cancer Cell 18, 382–395. doi:10.1016/j.ccr.2010.08.010
    OpenUrlCrossRefPubMedWeb of Science
  137. ↵
    1. Zhai, Y.,
    2. Kronebusch, P. J. and
    3. Borisy, G. G.
    (1995). Kinetochore microtubule dynamics and the metaphase-anaphase transition. J. Cell Biol. 131, 721–734. doi:10.1083/jcb.131.3.721
    OpenUrlAbstract/FREE Full Text
  138. ↵
    1. Zhang, J.,
    2. Neisa, R. and
    3. Mao, Y.
    (2009). Oncogenic Adenomatous polyposis coli mutants impair the mitotic checkpoint through direct interaction with Mad2. Mol. Biol. Cell 20, 2381–2388. doi:10.1091/mbc.E08-12-1206
    OpenUrlAbstract/FREE Full Text
  139. ↵
    1. Zhu, J.,
    2. Pavelka, N.,
    3. Bradford, W. D.,
    4. Rancati, G. and
    5. Li, R.
    (2012). Karyotypic determinants of chromosome instability in aneuploid budding yeast. PLoS Genet. 8, e1002719. doi:10.1371/journal.pgen.1002719
    OpenUrlCrossRefPubMed
Previous ArticleNext Article
Back to top
Previous ArticleNext Article

This Issue

Keywords

  • Mitosis
  • Spindle checkpoint
  • Cell cycle
  • Aneuploidy
  • Cancer
  • Mad1
  • Mad2

 Download PDF

Email

Thank you for your interest in spreading the word on Journal of Cell Science.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Mad1–Mad2 balancing act – a damaged spindle checkpoint in chromosome instability and cancer
(Your Name) has sent you a message from Journal of Cell Science
(Your Name) thought you would like to see the Journal of Cell Science web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Commentary
The Mad1–Mad2 balancing act – a damaged spindle checkpoint in chromosome instability and cancer
Scott C. Schuyler, Yueh-Fu Wu, Vivian Jen-Wei Kuan
Journal of Cell Science 2012 125: 4197-4206; doi: 10.1242/jcs.107037
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Commentary
The Mad1–Mad2 balancing act – a damaged spindle checkpoint in chromosome instability and cancer
Scott C. Schuyler, Yueh-Fu Wu, Vivian Jen-Wei Kuan
Journal of Cell Science 2012 125: 4197-4206; doi: 10.1242/jcs.107037

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Alerts

Please log in to add an alert for this article.

Sign in to email alerts with your email address

Article navigation

  • Top
  • Article
    • Summary
    • Introduction
    • The spindle checkpoint – a mechanism to ensure accurate chromosome segregation
    • Molecular mechanism of the spindle checkpoint – the central role of Mad1 and Mad2
    • Alterations in the levels of Mad1 or Mad2 cause aberrant spindle checkpoint function
    • The role of the Mad1:Mad2 ratio in spindle checkpoint function
    • Changes in Mad1 and Mad2 promote tumorigenesis
    • Models for how changes in Mad1 and Mad2 levels lead to a damaged checkpoint
    • How do changes in levels of Mad1 and Mad2 lead to chromosome instability?
    • Conclusions and perspectives
    • Acknowledgments
    • Footnotes
    • References
  • Figures & tables
  • Info & metrics
  • PDF

Related articles

Cited by...

More in this TOC section

  • Molecular mechanisms of kinesin-14 motors in spindle assembly and chromosome segregation
  • Lamins in the nuclear interior − life outside the lamina
  • Mechanisms of regulation and diversification of deubiquitylating enzyme function
Show more COMMENTARY

Similar articles

Other journals from The Company of Biologists

Development

Journal of Experimental Biology

Disease Models & Mechanisms

Biology Open

Advertisement

Introducing FocalPlane’s new Community Manager, Esperanza Agullo-Pascual

We are pleased to welcome Esperanza to the Journal of Cell Science team. The new Community Manager for FocalPlane, Esperanza is joining us from the Microscopy Core at Mount Sinai School of Medicine. Find out more about Esperanza in her introductory post over on FocalPlane.


New funding scheme supports sustainable events

As part of our Sustainable Conferencing Initiative, we are pleased to announce funding for organisers that seek to reduce the environmental footprint of their event. The next deadline to apply for a Scientific Meeting grant is 26 March 2021.


Read & Publish participation continues to grow

"Alongside pre-printing for early documentation of work, such mechanisms are particularly helpful for early-career researchers like me.”

Dr Chris MacDonald (University of York) shares his experience of publishing Open Access as part of our growing Read & Publish initiative. We now have over 150 institutions in 15 countries and four library consortia taking part – find out more and view our full list of participating institutions.


Cell scientist to watch: Romain Levayer

In an interview, Romain Levayer talks about starting his own lab, his love for preprints and his experience of balancing parenting with his research goals.


Live lactating mammary tissue

In a stunning video, Stewart et al. demonstrate warping of the alveolar unit due to basal cell-generated force as part of their recent work investigating roles for mechanically activated ion channels in lactation and involution.

Visit our YouTube channel to watch more videos from JCS, our sister journals and the Company.


JCS and COVID-19

For more information on measures Journal of Cell Science is taking to support the community during the COVID-19 pandemic, please see here.

If you have any questions or concerns, please do not hestiate to contact the Editorial Office.

Articles

  • Accepted manuscripts
  • Issue in progress
  • Latest complete issue
  • Issue archive
  • Archive by article type
  • Special issues
  • Subject collections
  • Interviews
  • Sign up for alerts

About us

  • About Journal of Cell Science
  • Editors and Board
  • Editor biographies
  • Travelling Fellowships
  • Grants and funding
  • Journal Meetings
  • Workshops
  • The Company of Biologists

For Authors

  • Submit a manuscript
  • Aims and scope
  • Presubmission enquiries
  • Fast-track manuscripts
  • Article types
  • Manuscript preparation
  • Cover suggestions
  • Editorial process
  • Promoting your paper
  • Open Access
  • JCS Prize
  • Manuscript transfer network
  • Biology Open transfer

Journal Info

  • Journal policies
  • Rights and permissions
  • Media policies
  • Reviewer guide
  • Sign up for alerts

Contacts

  • Contact JCS
  • Subscriptions
  • Advertising
  • Feedback

Twitter   YouTube   LinkedIn

© 2021   The Company of Biologists Ltd   Registered Charity 277992